The Drug-Induced Respiratory Disease Website
Including acute coronary artery disease or spasm and acute ST segment elevation on ECG/EKG. See also under Xg, XIIo and XIIaf
Publications
Ponatinib pulled off market over safety issues.
Managed care (Langhorne, Pa.) 2013 Dec;22;42-3 — 2013 Dec — 42-3
Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T,
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
The New England journal of medicine 2013 Nov 07;369;1783-96 — 2013 Nov 07 — 1783-96